脐血造血干细胞移植治疗血液病的应用研究进展
被引量:1
摘要
脐血是胎儿娩出、脐带结扎并离断后残留在胎盘和脐带中的血液,通常是废弃不用的。研究发现,脐血造血干细胞移植是利用脐带血中造血干细胞重建造血和免疫系统的一种治疗方法。脐血来源丰富,获取方便,
出处
《中国输血杂志》
CAS
CSCD
北大核心
2012年第3期283-285,共3页
Chinese Journal of Blood Transfusion
参考文献23
-
1Gluckman E.Ten years of cord blood transplantation:from bench tobedside.Br J Haematol 2009,147(2):192-199.
-
2Delaney C,Ratajczak MZ,Laughlin MJ.Strategies to enhance um-bilical cord blood stem cell engraftment in adult patients.ExpertRev Hematol,2010,3(3):273-283.
-
3Eapen M,Rubinstein P,Zhang MJ,et al.Outcomes of transplanta-tion of unrelated donor umbilical cord blood and bone marrow inchildren with acute leukaemia:a comparison study.Lancet,2007,369(9577):1947-1954.
-
4Sanz J,Sanz MA,Saavedra S,et al.Cord blood transplantation fromunrelated donors in adults with high-risk acute myeloid leukemia.Biol Blood Marrow Transplant,2010,16(1):86-94.
-
5Bachanova V,Verneris MR,DeFor T,et al.Prolonged survival in a-dults with acute lymphoblastic leukemia after reduced-intensityconditioning with cord blood or sibling donor transplantation.Blood,2009,113(13):2902-2905.
-
6Rocha V,Wagner JE,Sobocinski KA,et al.Graft-versus-host dis-ease in children who have received a cord blood or bone marrowtransplant from an HLA-identical sibling.N Engl J Med,2000,342(25):1846-1854.
-
7Sanz J,Montesinos P,Saavedra S,et al.Single-unit umbilical cordblood transplantation form unrelated donors in adult patients withchronic myelogenous leukemia.Biol Blood Marrow Transplant,2010,16(11):1589-1595.
-
8刘利,刘强,郝淼旺,陈任安,蒋姗姗,张继良,王黎红,何华,吴绒丽,杜娟,叶盛开,尹单单,梁英民.非清髓单倍体造血干细胞移植联合格列卫治疗慢性粒细胞白血病[J].临床血液学杂志,2006,19(1):3-6. 被引量:10
-
9Tomblyn M,Brunstein C,Burns LJet al.Similar and promising out-comes in lymphoma patients treated with myeloablative or nonmye-loablative conditioning and allogeneic hematopoietic cell transplan-tation.Biol Blood Marrow Transplant,2008,14(5):538-545.
-
10Brunstein CG,Cantero S,Cao Q,et al.Promising progression-freesurvival for patients low and intermediate grade lymphoid malignan-cies after nonmyeloablative unbilical cord blood transplantation.Bi-ol Blood Marrow Transplant,2009,15(2):214-222.
二级参考文献9
-
1Wadhwa J, Szydlo R M, Apperley J F, et al. Factors affecting duration of survival after onset of blastic trans-formation of chronic myeloid leukemia. Blood, 2002,99:2304-2309.
-
2Deininger M W, Golderman J M, Lydon N, et al. The tyrosine kinase inhibitor CGP571 48B selectively inhibits the growth of BCR-ABL positive cells. Blood, 1997,90:3691-3698.
-
3Champlin R, Khouri I, Shimoni A, et al. Harnessing graft versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation,an evolving strategy for adoptive immunotherapy. Br J Haematol, 2000, 111:18-29.
-
4Baker M B, Altman N H, Podack E R, et al. The role of cell-mediated cytotoxicity in acute GVHD after MHC-mediatedbone marrow transplantation in mice.JExp Med, 1996, 183:2645-2656.
-
5Harris D T, Sakiestewa D, Lyons C, et al. Prevention ofgraft-versus-host disease (GVHD) by elimination of recipi-ent-reactive donor T cells with recombinanttoxins thattargetthe interleukin2 (IL-2) receptor. Bone Marrow Transplantation, 1999, 23:137-144.
-
6Druker B J. Imatinib Alone and in Combination for Chronic Myeloid Leukemia. Seminars in Hematology,2003, 40:50-58.
-
7Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem ceil transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 1998,91:756-763.
-
8Druker B J, Talpaz M, Resta D J, et al. Effcacy and safety of a speci, c inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med,2001, 344:1031-1037.
-
9梁辉,王昀,邓晓辉,郭若冰,马静秋,陈文娟,余金妹.无关供体非清髓性干细胞移植治疗慢性粒细胞白血病1例[J].临床血液学杂志,2002,15(4):175-177. 被引量:1
共引文献9
-
1李春丽,赵娜,张王刚.白血病干细胞研究进展[J].临床血液学杂志,2007,20(4):252-255. 被引量:1
-
2邓姝,沈建平,沈一平,周郁鸿.中西医结合治疗慢性粒细胞白血病进展[J].浙江中医药大学学报,2008,32(3):417-418. 被引量:3
-
3熊礼凤.中西医结合治疗慢性粒细胞白血病现状及进展[J].现代肿瘤医学,2009,17(4):777-779. 被引量:4
-
4王谷云,姚红霞.慢性粒细胞白血病的治疗进展[J].医学综述,2009,15(13):1998-2000. 被引量:8
-
5杨英姿.中西医治疗慢性粒细胞白血病进展[J].实用中医药杂志,2010,26(6):445-446. 被引量:2
-
6朱磊,郭静明.慢性粒细胞白血病的治疗进展[J].航空航天医药,2010,21(8):1378-1379. 被引量:15
-
7郭子文,许晓军.亚砷酸对慢性白血病患者的影响[J].湖南中医药大学学报,2011,31(6):29-30. 被引量:1
-
8裴卫竑.中西医结合治疗慢性粒细胞白血病临床研究[J].中医学报,2013,28(7):935-936. 被引量:7
-
9穆雯,叶翎.慢性粒细胞白血病治疗进展[J].世界最新医学信息文摘,2016,16(A4):40-41. 被引量:2
同被引文献4
-
1滕皋军,卢勤.介入放射学的机遇:介入技术在生物靶向治疗中的应用与优势[J].介入放射学杂志,2007,16(2):73-74. 被引量:4
-
2褚海波,王旭翾.腔镜技术在腹部外科的应用及发展[J].实用医药杂志,2010,27(7):648-651. 被引量:2
-
3王占科,雷万生,常津.生物芯片研究现状及其在生物医学领域中的应用[J].解放军医学杂志,2011,36(5):545-546. 被引量:6
-
4王星岩.浅谈医学影像技术的现在与未来[J].中国现代药物应用,2011,5(24):139-140. 被引量:4
-
1魏成海.脐血及其临床应用[J].中国现代药物应用,2009,3(11):66-67. 被引量:1
-
2沈琼.异基因骨髓移植患者并发间质性肺炎的防治和护理[J].现代护理,2002,8(7):519-519. 被引量:3
-
3崔东岳(综述),孙自敏(审校).脐血移植后植入的规律和检测方法[J].国际输血及血液学杂志,2011,34(2):145-148.
-
4谭晓华.说说造血干细胞移植[J].抗癌之窗,2006,0(2):13-14.
-
5程中伟,沈悌.造血干细胞移植的临床应用[J].国外医学(移植与血液净化分册),2003,1(1):33-37.
-
6罗丹丹,侯秋秀,曾云菲,谭坚铃.1例异基因造血干细胞移植术后并发巨细胞病毒感染病人的护理[J].护理研究(上旬版),2013,27(5):1276-1277. 被引量:4
-
7顾小锋.脐血干细胞移植的移植物抗宿主病[J].国外医学(儿科学分册),2002,29(1):6-9. 被引量:1
-
8周乙华,姚集鲁.狂犬病疫苗应用研究进展[J].国外医学(内科学分册),1990,17(1):1-3. 被引量:1
-
9王春良.他汀类药物治疗高血脂的应用研究进展[J].中西医结合心血管病电子杂志,2014,2(15):40-41. 被引量:4
-
10代艳芬,高燕燕,牛佳鹏,董安华.GLP-1类似物在OSAHS治疗中应用研究进展[J].齐鲁医学杂志,2016,31(4):497-499. 被引量:3